Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1991-10-22
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0022-1899
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
164
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
829
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:1894953-Adult,
pubmed-meshheading:1894953-Animals,
pubmed-meshheading:1894953-Brain Diseases,
pubmed-meshheading:1894953-Humans,
pubmed-meshheading:1894953-Malaria,
pubmed-meshheading:1894953-Male,
pubmed-meshheading:1894953-Pentoxifylline,
pubmed-meshheading:1894953-Plasmodium falciparum,
pubmed-meshheading:1894953-Tumor Necrosis Factor-alpha
|
pubmed:year |
1991
|
pubmed:articleTitle |
Pentoxifylline in cerebral malaria.
|
pubmed:publicationType |
Letter,
Case Reports
|